Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1975;45:537-541
© 1975 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STOCK, R. J.
Right arrow Articles by KANBOUR, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STOCK, R. J.
Right arrow Articles by KANBOUR, A.

Prehysterectomy Curettage

RICHARD J. STOCK, MD, FACOG and ANISA KANBOUR, MD

From the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania.

The efficacy of prehysterectomy curettage in ruling out an endometrial cancer was evaluated in three ways. First, by an evaluation of the extent of routine prehysterectomy curettage; second, by the assessment of the clinicians' ability to recognize endometrial cancer on the basis of curettings; and third, by evaluating the presence of a gross endometrial lesion in those uteri removed without a preoperative diagnosis of an endometrial maligancy. It was concluded that the examination of the opened excised uterus was more valuable than prehysterectomy curettage for the operative diagnosis of an endometrial malignancy.




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
M K Heatley
Dissection and reporting of the organs of the female genital tract
J. Clin. Pathol., March 1, 2008; 61(3): 241 - 257.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
S. Duffy, T.L. Jackson, M. Lansdown, K. Philips, M. Wells, S. Pollard, G. Clack, M. Coibion, A.R. Bianco, and on behalf of the ATAC Trialists' Group
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy
Hum. Reprod., January 1, 2005; 20(1): 294 - 301.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. Smith-Bindman, K. Kerlikowske, V. A. Feldstein, L. Subak, J. Scheidler, M. Segal, R. Brand, and D. Grady
Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities
JAMA, November 4, 1998; 280(17): 1510 - 1517.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American College of Obstetricians and Gynecologists.